1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
-
Published:2022-01
Issue:1
Volume:15
Page:103545
-
ISSN:1878-5352
-
Container-title:Arabian Journal of Chemistry
-
language:en
-
Short-container-title:Arabian Journal of Chemistry
Author:
Tarawneh Amer H.,Pandey Pankaj,Al-Momani Lo'ay A.,Gadetskaya Anastassiya V.,Abu-Orabi Sultan T.,Doerksen Robert J.,Cutler Stephen J.
Funder
National Center for Research Resources National Institutes of Health National Institute of Mental Health National Institute of General Medical Sciences
Subject
General Chemical Engineering,General Chemistry
Reference53 articles.
1. (a) Berggren, A. I. K.; Bostrom, S. J.; Cheng, L.; Elebring, S. T.; Greasley, P.; Nagard, M.; Wilstermann, J. M.; Terricabras, E. WO2004058249, 2004.; (b) Francis, B.; Christian, C.; Laurent, H.; Murielle, R.-C. WO2006087476, 2006.; (c) Francis, B.; Christian, C.; Laurent, H.; Murielle, R.-C. WO2007000505, 2007. 2. (a) Berggren, A. I. K.; Bostrom, S. J.; Elebring, T. S.; Fallefors, L.; Wilstermann, J. M.; Greasley, P. WO2004058255, 2004.; (b) Lange, J.H., van Stuivenberg, H.H., Coolen, H.K., Adolfs, T.J., McCreary, A.C., Keizer, H.G., Wals, H.C., Veerman, W., Borst, A.J., de Looff, W. and Verveer, P.C., 2005. Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists. J. Med. Chem, 48(6), 1823-1838. https://doi.org/10.1021/jm040843r ; (c) Francis, B.; Murielle, R.-C. WO2007068815, 2007. 3. (a) Francis, B.; Christian, C.; Jean-Philippe, D.; Murielle, R.-C. WO2006077320, 2006.; (b) Francis, B.; Christian, C.; Jean-Philippe, D.; Murielle, R.-C. WO2006084975, 2006.; (c) Francis, B.; Christian, C.; Jean-Philippe, D.; Murielle, R.-C. WO2006070106, 2006. 4. (a) Jagerovic, N., Hernandez-Folgado, L., Alkorta, I., Goya, P., Martín, M.I., Dannert, M.T., Alsasua, Á., Frigola, J., Cuberes, M.R., Dordal, A. and Holenz, J., 2006. Structural–activity relationship study on C-4 carbon atom of the CB1 antagonist SR141716: synthesis and pharmacological evaluation of 1, 2, 4-triazole-3-carboxamides. Eur. J. Med. Chem, 41(1), pp.114-120. https://doi.org/10.1016/j.ejmech.2005.06.012 ; (b) Jagerovic, N., Hernandez-Folgado, L., Alkorta, I., Goya, P., Navarro, M., Serrano, A., Rodriguez de Fonseca, F., Dannert, M.T., Alsasua, A., Suardiaz, M. and Pascual, D., 2004. Discovery of 5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-3-hexyl-1 h-1, 2, 4-triazole, a novel in vivo cannabinoid antagonist containing a 1, 2, 4-triazole motif. J. Med. Chem, 47(11), 2939-2942. https://doi.org/10.1021/jm031099y ; (c) Pavon, F.J., Bilbao, A., Hernández-Folgado, L., Cippitelli, A., Jagerovic, N., Abellán, G., Rodríguez-Franco, M.I., Serrano, A., Macias, M., Gómez, R. and Navarro, M., 2006. Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-3-hexyl-1H-1, 2, 4-triazole–LH 21. Neuropharmacology, 51(2), 358-366. https://doi.org/10.1016/j.neuropharm.2006.03.029 ; (d) Francis, B.; Murielle, R.-C. WO2007068814, 2007. 5. (a) Plummer, C.W., Finke, P.E., Mills, S.G., Wang, J., Tong, X., Doss, G.A., Fong, T.M., Lao, J.Z., Schaeffer, M.T., Chen, J. and Shen, C.P., 2005. Synthesis and activity of 4, 5-diarylimidazoles as human CB1 receptor inverse agonists. BIOORG MED CHEM LETT, 15(5), 1441-1446. https://doi.org/10.1016/j.bmcl.2004.12.078
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|